Format

Send to

Choose Destination
Biomed Microdevices. 2004 Sep;6(3):231-9.

Opportunities for nanotechnology-based innovation in tissue proteomics.

Author information

1
FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. gehod@mail.nih.gov

Abstract

Within this review we discuss two methodologies used in tissue proteomics, namely mass-spectrometry (MS)-based protein pattern diagnostics and protein microarrays. Further, we describe current goals within the field of tissue proteomics and suggest points of departure for designing nanotechnology-based tools that will enhance the role of molecularly based diagnostics and therapeutics development in clinical medicine.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center